Implication of nanoparticles/microparticles in mucosal vaccine delivery

References

• Davis SS. Nasal vaccines. Adv. Drug Del. Rev.51, 21–42 (2001).
   PubMed Web of Science ®Google Scholar
• Nugent J, Po AL, Scott EM. Design and delivery of non-parenteral vaccines. J. Clin. Pharm. Ther.23(4), 257–285 (1998).
   PubMed Web of Science ®Google Scholar
• Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol.6, 148–158 (2006).
   PubMed Web of Science ®Google Scholar
• Mestecky J, Michalek SM, Moldoveanu Z, Russell MW. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Behring Inst. Mitt.98, 33–43 (1997).
   Google Scholar
• Czerkinsky C, Anjuere F, McGhee JR et al. Mucosal immunity and tolerance: relevance to vaccine development. Immunol. Rev.170, 197–222 (1999).
   PubMed Web of Science ®Google Scholar
• Hobson P, Bernfield C, Barnes A, Klavinskis L. Mucosal immunization with DNA vaccines. Methods31, 217–224 (2003).
   PubMed Web of Science ®Google Scholar
• McGhee JR, Lamm ME, Strober W. Mucosal immune responses: an overview. In: Mucosal Immunology (2nd Edition). Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (Eds). Academic Press, NY, USA 485–506 (1999).
   Google Scholar
• Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev.14, 430–445 (2001).
   PubMed Web of Science ®Google Scholar
• Sminia T, Kraal G. Nasal-associated lymphoid tissue. In: Mucosal Immunology (2nd Edition). Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (Eds). Academic Press, NY, USA 357– 379 (1999).
   Google Scholar
• Debertin AS, Tschernig T, Schurmann A, Bajanowski T, Brinkmann B, Pabst R. Coincidence of different structures of mucosa-associated lymphoid tissue (MALT) in the respiratory tract of children: no indications for enhanced mucosal immunostimulation in sudden infant death syndrome (SIDS). Clin. Exp. Immunol.146, 54–59 (2006).
   PubMed Web of Science ®Google Scholar
• Mestecky J, Moldoveanu Z, Russell MW. Immunologic uniqueness of the genital tract: challenge for vaccine development. Am. J. Reprod. Immunol.53, 208–214 (2005).
   PubMed Web of Science ®Google Scholar
• Stevceva L, Strober W. Mucosal HIV vaccines: where are we now? Curr. HIV Res.2, 1–10 (2004).
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C, Eriksson K, Mharandi A. Mucosal immunization and adjuvants: a brief overview of recent advances and challenges. Vaccine21(Suppl. 2), S89–S95 (2003).
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat. Med.11(Suppl. 4), S45–S53 (2005).
   PubMed Web of Science ®Google Scholar
• Eriksson K, Kilander A, Hagberg L, Norkrans G, Holmgren J, Czerkinsky C. Induction and expression of intestinal humoral immunity in HIV-infected individuals: prospects for vaccination against secondary enteric infections. Pathobiology66, 176–182 (1998).
   PubMed Web of Science ®Google Scholar
• Magistris MTD. Mucosal delivery of vaccine antigens and its advantages in pediatrics. Adv. Drug Del. Rev.58, 52–67 (2006).
   PubMed Web of Science ®Google Scholar
• Macian F. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol.5(6), 472–484 (2005).
   PubMed Web of Science ®Google Scholar
• Levine MM. Can needle-free administration of vaccines become the norm in global immunization? Nat. Med.9, 99–103 (2003).
   PubMed Web of Science ®Google Scholar
• Ryan EJ, Daly LM, Mills KHG. Immunomodulators and delivery systems for vaccination by mucosal routes. Trends Biotechol.19(8), 293–304 (2001).
   PubMed Web of Science ®Google Scholar
• Chen H. Recent advances in mucosal vaccine development. J. Control Rel.67, 117–128 (2000).
   PubMed Web of Science ®Google Scholar
• Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB, Viret J-F. Experience with registered mucosal vaccines. Vaccine21, 678–683 (2003).
   PubMed Web of Science ®Google Scholar
• Singh M, O’Hagan DT. The preparation and characterization of polymeric antigen delivery systems for oral administration. Adv. Drug Del. Rev.34, 285–304 (1998).
   PubMed Web of Science ®Google Scholar
• Andrianov AK, Payne LG. Polymeric carriers for oral uptake of microparticulates. Adv. Drug Del. Rev.34, 155–170 (1998).
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine24(19), 4201–4211 (2006).
   PubMed Web of Science ®Google Scholar
• Gupta PN, Mahor S, Rawat A, Khatri K, Goyal A, Vyas SP. Lectin anchored stabilized biodegradable nanoparticles for oral immunization: 1. Development and in-vitro evaluation. Int. J. Pharm.318, 163–173 (2006).
   PubMed Web of Science ®Google Scholar
• O’Hagan DT. The intestinal uptake of particles and the implications for drug and antigen delivery. J. Anat.189, 477–482 (1996).
   PubMed Web of Science ®Google Scholar
• Dea-Ayuela MA, Rama-Iniguez S, Torrado-Santiago S, Bolas-Fernandez F. Microcapsules formulated in the enteric coating copolymer Eudragit L100 as delivery systems for oral vaccination against infections by gastrointestinal nematode parasites. J. Drug Target.14, 567–575 (2006).
   PubMed Web of Science ®Google Scholar
• Tafaghodi M, Sajadi Tabasi SA, Jaafari MR. Formulation, characterization and release studies of alginate microspheres encapsulated with tetanus toxoid. J. Biomater. Sci. Poly. Ed.17, 909–924 (2006).
   PubMed Web of Science ®Google Scholar
• Sturesson C, Degling Wikingsson L. Comparison of poly (acryl starch) and poly (lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine. J. Control Rel.68, 441–450 (2000).
   PubMed Web of Science ®Google Scholar
• Litwin A, Flanagan M, Entis G et al. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy. Ann. Allergy Asthma Immunol.77, 132–138 (1996).
   PubMed Web of Science ®Google Scholar
• Haining WN, Anderson DG, Little SR et al. pH-triggered microparticles for peptide vaccination. J. Immunol.173, 2578–2585 (2004).
   PubMed Web of Science ®Google Scholar
• Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol.2, 361–367 (2001).
   PubMed Web of Science ®Google Scholar
• Payne LG, Jenkins SA, Andrianov AK, Roberts BE. Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery. In: Vaccine Design. Powell MF, Newman MJ (Eds). Plenum Press, NY, USA 473–493 (1995).
   Google Scholar
• Payne LG, Jenkins SA, Woods AL et al. Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine. Vaccine16, 92–98 (1998).
   PubMed Web of Science ®Google Scholar
• Jani P, McCarthy DE, Florence AT. Nanosphere and microsphere uptake via Peyer’s patches: observation of the rate of uptake in the rat after a single oral dose. Int. J. Pharm.86, 239–246 (1992).
   Web of Science ®Google Scholar
• Florence AT. Nanoparticle uptake by oral route: fulfilling its potential? Drug Dis. Today2, 75–81 (2005).
   Google Scholar
• Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there is a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm.50, 147–160 (2000).
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hawley AE, Christy NM, Gray T, Illum L, Davis SS. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett.344, 25–30 (1994).
   PubMed Web of Science ®Google Scholar
• Shakweh M, Besnard M, Nicolas V, Fattal E. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer’s paches in mice. Eur. J. Pharm. Biopharm.61, 1–13 (2005).
   PubMed Web of Science ®Google Scholar
• Le Ray AM, Vert M, Gautier JC, Benoit JP. Fate of poly (DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice. Int. J. Pharm.106, 201–211 (1994).
   Web of Science ®Google Scholar
• Eyles J, Alpar HO, Field WN, Lewis DA, Keswick M. The transfer of polystyrene microspheres from the gastrointestinal tract to the circulation after oral administration in the rat. J. Pharm. Pharmacol.47, 561–565 (1995).
   PubMed Web of Science ®Google Scholar
• Norris DA, Puri N, Sinko PJ. The effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug Del. Rev.34, 135–154 (1998).
   PubMed Web of Science ®Google Scholar
• Migliaresi C, Fambri L, Cohn D. A study on the in vitro degradation of poly (lactic acid). J. Biomat. Sci. Poly. Ed.5, 591–606 (1994).
   PubMed Web of Science ®Google Scholar
• Cleek RL, Ting KC, Eskin SG, Mikos AG. Microparticles of poly (dl-lactic-co-glycolic acid)/poly (ethylene glycol) blends for controlled drug delivery. J. Control Rel.48, 259–268 (1997).
   Web of Science ®Google Scholar
• O’Hagan DT, Jeffery H, Davis SS. The preparation and microcharacterization of poly (lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of model proteins. Int. J. Pharm.103, 37–45 (1994).
   Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control Rel.82, 105–114 (2002).
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Singh P, Prabakaran D, Mishra V, Vyas SP. Development of a single-dose stabilized poly (d,l-lactic-co-glycolic acid) microsphere-based vaccine against hepatitis B. J. Pharm. Pharmacol.56, 1243–1250 (2004).
   PubMed Web of Science ®Google Scholar
• Pappo J, Ermak TH. Uptake and translocation of fluorescent latex particle by rabbit Peyer’s patch follicle epithalium: a quantitative model for M cell uptake. Clin. Exp. Immunol.76, 227–280 (1989).
   PubMed Web of Science ®Google Scholar
• Le Fever ME, Boccio AM, Jeol DD. Intestinal uptake of fluorescent microsphere in young and aged mice. Proc. Soc. Exp. Biol. Med.190, 23–27 (1989).
   PubMed Web of Science ®Google Scholar
• Simon L, Shine G, Dayan, AD. Effect of animal age on the uptake of large particulates across the epithelium of rat small intestine. Int. J. Exp. Pathol.75, 369–373 (1994).
   PubMed Web of Science ®Google Scholar
• Strous GJ, Dekker J. Mucin-type glycoproteins. Crit. Rev. Biochem. Mol. Biol.27, 57–92 (1992).
   PubMed Web of Science ®Google Scholar
• Desai MA, Mutlu M, Vadgama P. A study of macro-molecular diffusion through native porcine mucus. Experientia48, 22–26 (1992).
   PubMedGoogle Scholar
• Brayden DJ, Jepson MA, Baird AW. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov. Today10, 1145–1157 (2005).
   PubMed Web of Science ®Google Scholar
• Lo D, Tynan W, Dickerson J et al. Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle associated epithelium of Peyer’s patch by expression profiling of Caco-2/Raji co-cultures. Int. Immunol.16, 91–99 (2004).
   PubMed Web of Science ®Google Scholar
• Lo D, Tynan W, Dickerson J et al. Peptidoglycan recognition protein expression in mouse Peyer’s patch follicle associated epithelium suggests functional specialization. Cell Immunol.224, 8–16 (2003).
   PubMed Web of Science ®Google Scholar
• Vyas SP, Singh A, Sihorkar V. Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. Crit. Rev. Ther. Drug Carrier Syst.18, 1–76 (2001).
   PubMed Web of Science ®Google Scholar
• Foster N, Clark MA, Jepson MA, Hirst BH. Ulex europaeus 1 lectin targets microspheres to mouse Peyer’s patch M-cells in vivo. Vaccine16, 536–541 (1998).
   PubMed Web of Science ®Google Scholar
• Giannasca PJ, Giannasca KT, Leichtner AM, Neutra MR. Human intestinal M cells display the sialyl Lewis A antigen. Infect. Immun.67, 946–953 (1999).
   PubMed Web of Science ®Google Scholar
• Singh P, Prabakaran D, Jain S, Mishra V, Jaganathan KS, Vyas SP. Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int. J. Pharm.278, 379–390 (2004).
   PubMed Web of Science ®Google Scholar
• Jain S, Vyas SP. Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J. Lipo. Res.16, 331–345 (2006).
   Google Scholar
• Henderson B, Poole S, Wilson M. Bacterial modulins: novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev.60, 316–341 (1996).
   PubMedGoogle Scholar
• Young VB, Falkow S, Schoolnik GK. The invasin protein of Yersinia enterocolitica: internalization of invasin bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton. J. Cell Biol.116, 197–207 (1992).
   PubMed Web of Science ®Google Scholar
• Jepson MA, Clark MA. Studying M cells and their role in infection. Trends Microbiol.6, 359–365 (1998).
   PubMed Web of Science ®Google Scholar
• Clark MA, Hirst BH, Jepson MA. Lectin-mediated mucosal delivery of drugs and microparticles. Adv. Drug Del. Rev.43, 207–223 (2000).
   PubMed Web of Science ®Google Scholar
• Durrer C, Irache JM, Duchene D, Ponchel G. Study of the interactions between nanoparticles and intestinal mucosal. Prog. Colloid. Polym. Sci.97, 275–280 (1994).
   Google Scholar
• Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun.65, 1387–1394 (1997).
   PubMed Web of Science ®Google Scholar
• Uchida T, Martin S, Foster TP, Wardley RC, Grimm S. Dose and load studies for subcutaneous and oral delivery of poly (lactide-co-glycolide) microspheres containing ovalbumin. Pharm. Res.11, 1009–1015 (1994).
   PubMed Web of Science ®Google Scholar
• Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuole R. The design of vaccine against Helicobacter pylori and their development. Annu. Rev. Immunol.19, 523–563 (2001).
   PubMed Web of Science ®Google Scholar
• Kim SY, Doh HJ, Ahn JS et al. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysate encapsulated in poly(D,L-lactide-co-glycolide) microparticles. Vaccine17, 607–616 (1999).
   PubMed Web of Science ®Google Scholar
• Partidos CD. Intranasal vaccines: forthcoming challenges. Pharm. Sci. Technolo. Today3, 273–281 (2000).
   PubMedGoogle Scholar
• Wu HY, Russell MW. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol. Res.16, 187–201 (1997).
   PubMed Web of Science ®Google Scholar
• Yanagita M, Hiroi T, Kitagaki N et al. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J. Immunol.162, 3559–3565 (1999).
   PubMed Web of Science ®Google Scholar
• Shahin R, Leef M, Eldridge JH, Hudson M, Gilley RM. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres. Infect. Immun.63, 1195–1200 (1995).
   PubMed Web of Science ®Google Scholar
• Moore A, McGuirk P, Adams S et al. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD81 cytotoxic T lymphocytes and CD41 Th1 cells. Vaccine13, 1741–1749 (1995).
   PubMed Web of Science ®Google Scholar
• Zhou F, Kraehenbuhl J-P, Neutra MR. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine13, 637–644 (1995).
   PubMed Web of Science ®Google Scholar
• Bergmeier LA, Tao L, Gearing AJM, Adams S, Lehner T. Comparison of IgA antibodies in vaginal and rectal fluids, serum and saliva following immunization of genital and gut-associated lymphoid tissue. In: Proc. 7th Int. Cong. Mucosal Immunol. Excerpta Medica, Amsterdam, The Netherlands 23 (1992).
   Google Scholar
• O’Hagan DT, Rafferty D, Wharton S, Illum L. Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system. Vaccine11, 660–664 (1993).
   PubMed Web of Science ®Google Scholar
• Tommaso AD, Saletti G, Pizza M et al. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heal labile enterotoxin as mucosal adjuvant. Infect. Immun.64, 974–979 (1996).
   PubMed Web of Science ®Google Scholar
• Olaguibel JM, Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children: conclusions from one meta-analysis. J. Investig. Allergol. Clin. Immunol.15, 9–16 (2005).
   PubMed Web of Science ®Google Scholar
• Van Overtvelt L, Razafindratsita A, St-Lu N et al. Sublingual vaccines based on wild-type recombinant allergens. Allerg. Immunol. (Paris)38, 247–249 (2006).
   Google Scholar
• Wheeler AW, Sharif S. Sublingual delivery of vaccines: can we enhance the immune response induced via this route? Eur. J. Pharm. Sci.4, S39 (1996).
   Web of Science ®Google Scholar
• Akdis CA, Barlan IB, Bahceciler N, Akdis M. Immunological mechanisms of sublingual immunotherapy. Allergy61, 11–14 (2006).
   PubMed Web of Science ®Google Scholar
• Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy61, 151–165 (2006).
   PubMed Web of Science ®Google Scholar
• Dilraj A, Cutts FT, de Castro JF et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomized trial. Lancet355, 798–803 (2000).
   PubMed Web of Science ®Google Scholar
• Nesburn AB, Burke RL, Ghiasi H, Slanina SM, Wechsler SL. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus specific tear secretory immunoglobulin A than systemic vaccination and provide protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits. Virology252, 200–209 (1998).
   PubMed Web of Science ®Google Scholar
• Coffin SE, Offit PA. Induction of mucosal B-cell memory by intramuscular inoculation of mice with rotavirus. J. Virol.72, 3479–3483 (1998).
   PubMed Web of Science ®Google Scholar
• Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Del. Rev.28, 5–24 (1997).
   PubMed Web of Science ®Google Scholar
• Cadee JA, Brouwer LA, den Otter W, Hennink WE, van Luyn MJ. A comparative biocompatibility study of microspheres based on cross-linked dextran or poly(lactic-co-glycolic) acid after subcutaneous injection in rats. J. Biomed. Mater. Res.56, 600–609 (2001).
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization. Fed. Regist.62, 24302–24309 (1997).
   Google Scholar
• Niu CH, Chiu YY. FDA perspective on peptide formulations and stability issues. J. Pharm. Sci.87, 1331–1334 (1998).
   PubMed Web of Science ®Google Scholar
• Jain S, Singh P, Mishra V, Vyas SP. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol. Lett.101, 41–49 (2005).
   PubMed Web of Science ®Google Scholar
• Jain S, Sharma RK, Vyas SP. Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization. J. Pharm. Pharmacol.58, 303–310 (2006).
   PubMed Web of Science ®Google Scholar
• Banerjee S, Medina-Fatimi A, Nichols R et al. Safety and efficacy of low-dose Escherichia coli enterotoxin adjuvant for urease-based oral immunization against Helicobacter pylori in healthy volunteers. Gut51, 634–640 (2002).
   PubMed Web of Science ®Google Scholar
• Metzger WG, Mansouri E, Kronawitter M et al. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar Typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine22, 2273–2277 (2004).
   PubMed Web of Science ®Google Scholar
• Smythies LE, Novak MJ, Waites KB, Lindsey JR, Morrow CD, Smith PD. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection. Vaccine23, 901–909 (2005).
   PubMed Web of Science ®Google Scholar
• Durrer P, Gluck U, Spyr C et al. Mucosal antibody response induced with a nasal virosome-based influenza vaccine. Vaccine21, 4328–4334 (2003).
   PubMed Web of Science ®Google Scholar
• Clark MA, Blair H, Liang L, Brey RN, Brayden D, Hirst B. Targeting polymerized liposome vaccine carrier to intestinal M cells. Vaccine20, 208–271 (2002).
   Web of Science ®Google Scholar
• Perez O, Bracho G, Lastre M et al. Proteoliposome-derived cochleate as an immunomodulator for nasal vaccine. Vaccine24(Suppl. 2), S52–S53 (2006).
   Web of Science ®Google Scholar
• Alpar HO, Somavarapu S, Atuah KN, Bramwell VW. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv. Drug Deliv. Rev.57, 411–430 (2005).
   PubMed Web of Science ®Google Scholar
• Kozlowski PA, Williams SB, Lynch RM et al. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal or vaginal immunization: influence of the menstrual cycle. J. Immunol.169, 566–574 (2002).
   PubMed Web of Science ®Google Scholar
• Aguila A, Donachie AM, Peyre M, McSharry CP, Sesardic D, Mowat AM. Induction of protective and mucosal immunity against diphtheria by an immune stimulating complex (ISCOMS) based vaccine. Vaccine24, 5201–5210 (2006).
   PubMed Web of Science ®Google Scholar
• Rice J, Ainlev WM, Shewen P. Plant-made vaccines: biotechnology and immunology in animal health. Anim. Health Res. Rev.6, 199–209 (2005).
   PubMedGoogle Scholar
• Thanavala Y, Mahoney M, Pal S et al. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl Acad. Sci. USA102, 3378–3382 (2005).
   PubMed Web of Science ®Google Scholar
• Holmgren J, Bergquist C. Oral B subunit killed whole-cell cholera vaccines. In: New Generation Vaccines (3rd Edition). Levine MM (Ed.). Marcel Decker, NY, USA (2004).
   Google Scholar
• Richie EE, Punjabi NH, Sidharta YY et al. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine18, 2399–2410 (2000).
   PubMed Web of Science ®Google Scholar
• De Vos B, Vesikari T, Linhares AC et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr. Infect. Dis. J.23, S179–S182 (2004).
   PubMed Web of Science ®Google Scholar
• Svennerholm AM, Steele D, Microbial gut interactions in health and disease: progress in enteric vaccine development. Best Pract. Res. Clin. Gastroenterol.18, 421–445 (2004).
   PubMed Web of Science ®Google Scholar
• Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies: comparison of immune responses to inactivated and live attenuated influenza vaccines. Scand. J. Immunol.59, 1–15 (2004).
   PubMed Web of Science ®Google Scholar
• Mitragotri S. Immunization without needles. Nat. Rev. Immunol.5, 905–916 (2005).
   PubMed Web of Science ®Google Scholar
• Wilson DR, Torres Lima M, Dirham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy60, 4–12 (2005).
   PubMed Web of Science ®Google Scholar
• Seal M, Arnon R, Schechter B. Therapeutic vaccines: realities of today and hopes for the future. Drug Dis. Today7, 664–672 (2002).
   PubMed Web of Science ®Google Scholar
• Clark MA, Jepson MA, Simmons NL, Hirst BH. Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer’s patch M-cells in vivo. Cell Tissue Res.282, 455–461 (1995).
   PubMed Web of Science ®Google Scholar
• Chen H, Torchilin V, Langer R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res.13, 1378–1383 (1996).
   PubMed Web of Science ®Google Scholar
• Kabok Z, Ermak TH, Pappo J. Microheterogeneity of follicle epithelium and M cells in rabbit gut-associated lymphoid tissues defined by monoclonal antibodies. FASEB J.8, A1008 (1994).
   Google Scholar
• Carreno-Gomez B, Woodley JF, Florence AT. Studies on the uptake of tomato lectin nanoparticles in everted gut sacs. Int. J. Pharm.183, 7–11 (1999).
   PubMed Web of Science ®Google Scholar
• Porta C, James PS, Phillips AD, Savidge TC, Smith MW, Cremaschi D. Confocal analysis of fluorescent bead uptake by mouse Peyer’s patch follicle-associated M cells. Exp. Physiol.77, 929–932 (1992).
   PubMed Web of Science ®Google Scholar
• Giannasca PJ, Boden JA, Monath TP. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect. Immun.65, 4288–4298 (1997).
   PubMed Web of Science ®Google Scholar
• Hussain N, Florence AT. Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles. Pharm. Res.15, 153–156 (1998).
   PubMed Web of Science ®Google Scholar
• Harokopakis E, Childers NK, Michalek SM, Zhang SS, Tomasi M. Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens. J. Immunol. Meth.185, 31–42 (1995).
   PubMed Web of Science ®Google Scholar
• Conacher M, Alexander J, Brewer JM. Oral immunization with peptide and protein antigens by formulations in lipid vesicles incorporating bile salts (bilosomes). Vaccine19, 2965–2974 (2001).
   PubMed Web of Science ®Google Scholar